SBH
IRWD icon

Segall Bryant & Hamill’s Ironwood Pharmaceuticals IRWD Stock Holding History

Segall Bryant & Hamill’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
408,064
+129,863
+47% +$501K 0.02% 474
2026
Q1 		$976K Buy
+278,201
New +$1.14M 0.01% 509

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Segall Bryant & Hamill's IRWD Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Ironwood Pharmaceuticals (IRWD) stake by 47% in Q2 2026, buying an estimated $501K and bringing the position to 408,064 shares worth $1.72M. The position accounts for 0.02% of the portfolio, ranked #474.

Segall Bryant & Hamill first reported a position in IRWD in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Segall Bryant & Hamill held 408,064 shares of Ironwood Pharmaceuticals worth $1.72M as of Q2 2026.
  • Segall Bryant & Hamill bought 129,863 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $501K.
  • Ironwood Pharmaceuticals made up 0.02% of Segall Bryant & Hamill's portfolio in Q2 2026, its #474 holding.
  • Segall Bryant & Hamill first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.